BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4050909)

  • 1. Hormonal and morphologic effects of bromocriptine on normal rat pituitary and GH3 tumor cells.
    Lahteenmaki P; Marrs RP; Schechter J; Zacharias S; Kletzky OA
    Am J Obstet Gynecol; 1985 Oct; 153(4):349-57. PubMed ID: 4050909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bromocriptine on experimental GH3 cell tumors.
    Kamijo K; Sato M; Saito T; Yachi A; Minase T
    Pathol Res Pract; 1991 Jun; 187(5):593-7. PubMed ID: 1923956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells.
    Johansen PW; Haug E; Gautvik KM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):200-6. PubMed ID: 4060970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells.
    Dembinski TC; Leung CK; Shiu RP
    Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monolayer and suspension culture of human prolactin-secreting pituitary adenoma.
    Kletzky OA; Marrs RP; Rundall TT; Weiss MH; Beierle JW
    Am J Obstet Gynecol; 1980 Nov; 138(6):660-4. PubMed ID: 7435530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA synthesis and depletion of prolactin in the pituitary gland of the male rat.
    Lloyd HM; Jacobi JM; Meares JD
    J Endocrinol; 1978 Apr; 77(1):129-36. PubMed ID: 641429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bromocriptine on cell cycle distribution and cell morphology in cultured rat pituitary adenoma cells.
    Johansen PW; Clausen OP; Haug E; Fossum S; Gautvik KM
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):319-28. PubMed ID: 4072574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H; Refetoff S; Fang VS
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethal effects of the combination of hyperthermia and bromocriptine or a somatostatin analogue on normal pituitary cells and pituitary tumour cells.
    Kawamoto K; Uozumi T; Yano T; Arita K; Kurisu K; Kiya K
    Int J Hyperthermia; 1992; 8(6):747-54. PubMed ID: 1479200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis.
    Lee SY; Ahn BT; Baik SH; Lee BL
    Neurosurgery; 1998 Jul; 43(1):116-23. PubMed ID: 9657197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of latent tissue kallikrein, prolactin and growth hormone secretion in GH3 pituitary cells using modified radioimmunoassays.
    Chao J; Chao L
    Mol Cell Endocrinol; 1988 Jan; 55(1):21-31. PubMed ID: 3360206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bromocriptine, somatostatin, and oestradiol-17 beta on hormone secretion and ultrastructure of human pituitary tumours in vitro.
    Prysor-Jones RA; Kennedy SJ; O'Sullivan JP; Jenkins JS
    Acta Endocrinol (Copenh); 1981 Sep; 98(1):14-23. PubMed ID: 6116372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypersecretion of growth hormone and prolactin on plasma levels of glucagon and insulin in GH3-cell-tumor-bearing rats, and the influence of bromocriptine treatment.
    Knudtzon J; Johansen PW; Haug E; Gautvik K
    Life Sci; 1986 Aug; 39(7):617-21. PubMed ID: 3526070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of bromocriptine and oestrogen on prolactin synthesis, secretion and tumour growth in vivo in rats.
    Vrontakis ME; Thliveris JA; Friesen HG
    J Endocrinol; 1987 Jun; 113(3):383-8. PubMed ID: 3625096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone.
    Cronin MJ; Perkins SN; Keefer DA; MacLeod RM
    Mol Cell Endocrinol; 1982 Oct; 28(2):229-46. PubMed ID: 7128925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Day RN; Hinkle PM
    Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of bromocriptine on estrogen-induced rat prolactinoma].
    Otsuka R
    Neurol Med Chir (Tokyo); 1987 Jun; 27(6):475-81. PubMed ID: 2448665
    [No Abstract]   [Full Text] [Related]  

  • 19. Subcellular distribution of secretogranins I and II in GH3 rat tumoral prolactin (PRL) cells as revealed by electron microscopic immunocytochemistry.
    Tougard C; Nasciutti LE; Picart R; Tixier-Vidal A; Huttner WB
    J Histochem Cytochem; 1989 Sep; 37(9):1329-36. PubMed ID: 2671150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the ultrastructural distribution of prolactin and growth hormone mRNAs in pituitary cells of female rats after estrogen and bromocriptine treatment, studied using in situ hybridization with biotinylated oligonucleotide probes.
    Matsuno A; Ohsugi Y; Utsunomiya H; Takekoshi S; Sanno N; Osamura RY; Watanabe K; Teramoto A; Kirino T
    Histochem Cell Biol; 1995 Jul; 104(1):37-45. PubMed ID: 7584558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.